Introduction {#ejn13191-sec-0001}
============

Microglia are brain‐resident macrophage‐like cells of the central nervous system, and have been recently acknowledged as synaptic partners (Ben Achour & Pascual, [2010](#ejn13191-bib-0005){ref-type="ref"}; Tremblay *et al*., [2010](#ejn13191-bib-0061){ref-type="ref"}; Kettenmann *et al*., [2013](#ejn13191-bib-0028){ref-type="ref"}). Microglia modulate neuronal activity in both physiological and pathophysiological conditions (Bessis *et al*., [2007](#ejn13191-bib-0006){ref-type="ref"}; Roumier *et al*., [2008](#ejn13191-bib-0054){ref-type="ref"}; Wake *et al*., [2009](#ejn13191-bib-0063){ref-type="ref"}) through signalling mechanisms that are largely unknown. Purines are candidate signals, as microglia can release ATP (Pascual *et al*., [2012](#ejn13191-bib-0045){ref-type="ref"}; George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}), which modulates synaptic transmission and plasticity (Neary & Zimmermann, [2009](#ejn13191-bib-0041){ref-type="ref"}; Verkhratsky *et al*., [2009](#ejn13191-bib-0062){ref-type="ref"}; Burnstock *et al*., [2011](#ejn13191-bib-0008){ref-type="ref"}; Rodrigues *et al*., [2015](#ejn13191-bib-0053){ref-type="ref"}).

ATP has pleiotropic effects in the brain, which depend on different types of purinergic receptors expressed by neurons and glial cells, but also on its degradation by extracellular ectonucleotidases to adenosine (Burnstock *et al*., [2011](#ejn13191-bib-0008){ref-type="ref"}; Rodrigues *et al*., [2015](#ejn13191-bib-0053){ref-type="ref"}). Purinergic receptors are divided into two families activated either by adenosine (P1 receptors) or by ATP (P2 receptors). P1 receptors are G‐protein‐coupled, and comprise four different subtypes: A~1~, A~2A~, A~2B~, and A~3~ (Fredholm *et al*., [2011](#ejn13191-bib-0019){ref-type="ref"}). The P2 receptor family is subdivided in two subfamilies: the ionotropic P2X receptors (P2X receptors 1--7) family linked to increased cation permeability, and the metabotropic P2Y receptors (eight different subtypes) family coupled to G‐proteins (Burnstock *et al*., [2011](#ejn13191-bib-0008){ref-type="ref"}).

P1 and P2 receptors are widely distributed at brain synapses. In the hippocampus, A~1~ receptors (A~1~Rs) are located at both presynaptic and postsynaptic loci (Rebola *et al*., [2003](#ejn13191-bib-0048){ref-type="ref"}), whereas A~2A~ receptors (A~2A~Rs) are mostly presynaptic (Rebola *et al*., [2005](#ejn13191-bib-0049){ref-type="ref"}), but are also present in astrocytes (Matos *et al*., [2012](#ejn13191-bib-0038){ref-type="ref"}) and microglia (Rebola *et al*., [2011](#ejn13191-bib-0051){ref-type="ref"}). Adenosine decreases glutamatergic transmission via presynaptic A~1~Rs (Dunwiddie & Masino, [2001](#ejn13191-bib-0018){ref-type="ref"}), whereas it activates A~2A~Rs to facilitate AMPA and *N*‐methyl‐[d]{.smallcaps}‐aspartate receptor‐mediated currents (Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}; Dias *et al*., [2012](#ejn13191-bib-0016){ref-type="ref"}) to modulate synaptic plasticity (Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}; Costenla *et al*., [2011](#ejn13191-bib-0012){ref-type="ref"}).

P2X receptors also modulate hippocampal synaptic transmission and plasticity (Pankratov *et al*., [2002](#ejn13191-bib-0044){ref-type="ref"}). Presynaptic P2X~2~ receptors facilitate CA3 excitatory transmission onto interneurons in the CA1 region (Khakh *et al*., [2003](#ejn13191-bib-0030){ref-type="ref"}), whereas P2X~4~ receptors (P2X~4~Rs) tune the *N*‐methyl‐[d]{.smallcaps}‐aspartate receptor‐dependent component of long‐term plasticity at the Schaffer--collateral CA1 synapse (Sim *et al*., [2006](#ejn13191-bib-0058){ref-type="ref"}). This is in accordance with the expression of P2X~2~, P2X~3~, P2X~4~ and P2X~6~ receptor subunits by hippocampal neurons (Rodrigues *et al*., [2005](#ejn13191-bib-0052){ref-type="ref"}), whereas P2X~7~ receptors are mostly expressed by activated glial cells (Butt, [2011](#ejn13191-bib-0009){ref-type="ref"}).

In this study, we investigated the role of microglia--purine interactions at hippocampal synapses between mossy fibres (MFs) and CA3 pyramidal cells. MF‐CA3 synapses show prominent forms of presynaptic plasticity (Marchal & Mulle, [2004](#ejn13191-bib-0037){ref-type="ref"}; Nicoll & Schmitz, [2005](#ejn13191-bib-0043){ref-type="ref"}), and are instrumental in the encoding and retrieval of memories (Nakazawa *et al*., [2003](#ejn13191-bib-0040){ref-type="ref"}; Bischofberger *et al*., [2006](#ejn13191-bib-0007){ref-type="ref"}; Kesner, [2007](#ejn13191-bib-0026){ref-type="ref"}). We report that ATP and adenosine, derived from lipopolysaccharide (LPS)‐challenged microglia (George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}), do modulate synaptic transmission and short‐term plasticity at MF‐CA3 synapses by acting, respectively, on P2X~4~Rs and A~1~Rs. This study reveals an interplay between microglia and MF‐CA3 synapses, and further supports microglia as true modulators of neuronal network through purinergic modulation of presynaptic function.

Materials and methods {#ejn13191-sec-0002}
=====================

Ethical approval {#ejn13191-sec-0003}
----------------

Experiments were carried out in accordance with the guidelines on the ethical use of animals from the European Communities Council Directive (86/609/EEC) and were evaluated by the Ethics commitee n°50 of Bordeaux, affiliated with the CNREEA (Centre National de Réflexion Ethique sur l\'Expérimentation Animale).

Microglial cell culture and pharmacological treatment {#ejn13191-sec-0004}
-----------------------------------------------------

A murine microglial cell line, N9 (a gift from C. Verderio, CNR Institute of Neuroscience, Cellular and Molecular Pharmacology, Milan, Italy), was grown in RPMI‐1640 (Sigma, St Quentin Fallavier, France) medium supplemented with 30 m[m]{.smallcaps} glucose (Sigma), 5% heat‐inactivated fetal bovine serum (Gibco, Invitrogen, Merelbeke, Belgium), 100 μg/mL streptomycin, and 1 U/mL penicillin (Gibco, Invitrogen). Cells were kept at 37 °C under a humidified atmosphere with 95% O~2~ and 5% CO~2~. In order to trigger microglia activation and ATP release, N9 cells were challenged with 100 ng/mL LPS (from *Escherichia coli*, serotype 055:B5; Sigma) for 1 h, which we have found to trigger ATP release and upregulation of A~2A~Rs (Gomes *et al*., [2013](#ejn13191-bib-0023){ref-type="ref"}).

Slice preparation {#ejn13191-sec-0005}
-----------------

C57BL6/J mice (Janvier Labs, Le Genest St Isle, France) were killed at postnatal day (P)19--P21 by cervical dislocation. The brain was then quickly removed from the skull, and chilled in ice‐cold low‐calcium artificial cerebrospinal fluid containing 87 m[m]{.smallcaps} NaCl, 2.5 m[m]{.smallcaps} KCl, 1.25 m[m]{.smallcaps} NaH~2~PO~4~, 0.5 m[m]{.smallcaps} CaCl~2~, 7 m[m]{.smallcaps} MgCl~2~, 10 m[m]{.smallcaps} glucose, 25 m[m]{.smallcaps} NaHCO~3~, and 75 m[m]{.smallcaps} sucrose, adjusted to pH 7.4 by saturating with carbogen (95% O~2~ and 5% CO~2~), and with an osmolarity of 300--310 mOsm. Brains were then glued onto the stage of a vibratome (VT 1200S; Leica, Nusslich, Germany), and parasagittal hippocampal slices (320 μm) were cut. Slices were then transferred to an extracellular solution containing 129 m[m]{.smallcaps} NaCl, 2.5 m[m]{.smallcaps} KCl, 1.25 m[m]{.smallcaps} NaH~2~PO~4~, 2 m[m]{.smallcaps} CaCl~2~, 1 m[m]{.smallcaps} MgCl~2~, 11 m[m]{.smallcaps} glucose, and 25 m[m]{.smallcaps} NaHCO~3~, equilibrated with carbogen for 30 min at 33 °C and thereafter at room temperature, until being used.

Electrophysiology {#ejn13191-sec-0006}
-----------------

The slices were submerged in a recording chamber and continuously superfused with carbogen‐saturated extracellular solution at 32--34 °C. Whole cell patch clamp recordings were made at a holding potential of −70 mV with electrodes of 3--4 MΩ. Patch clamp electrodes were pulled out from borosilicate glass (GF 150 F‐10; Clark Electromedical, Reading, UK), and filled with an internal solution containing 140 m[m]{.smallcaps} CsCH~3~SO~3~, 2 m[m]{.smallcaps} MgCl~2~, 4 m[m]{.smallcaps} NaCl, 5 m[m]{.smallcaps} phosphocreatine, 2 m[m]{.smallcaps} Na~2~ATP, 0.2 m[m]{.smallcaps} EGTA, 10 m[m]{.smallcaps} HEPES, and 0.33 m[m]{.smallcaps} GTP (pH 7.3), adjusted with CsOH. Bicuculline (10 μ[m]{.smallcaps}) was added to the bath to inhibit GABA~A~ receptors.

Voltage‐clamp recordings were performed on CA3 pyramidal neurons visualized with a differential interference contrast microscope (Eclipse FN‐1; Nikon, Champigny sur Marne, France) equipped with an infrared camera (VX44; Till Photonics, Gräfelfing, Germany), by use of an Axoptach‐200B amplifier (Axon Instruments, Sunnydale, CA, USA). Signals were filtered at 2 kHz and digitized at 5 kHz via a DigiData 1322A interface (Axon Instruments). Series resistance (10--20 MΩ) was monitored during the recording with a −10 mV hyperpolarizing voltage step (length, 50 ms) delivered at the beginning of each recording. Neurons were rejected if the series resistance changed by \>20% during the experiment. Neurons with a holding current of \>300 pA at a holding potential of −70 mV were rejected. Data were collected and analysed with [pclamp]{.smallcaps} software 9.2 (Axon Instruments). N9 microglia were challenged with LPS (100 ng/mL) for 1 h or not challenged, before being added to the slices. The cells were trypsinized and collected, and then added to a hippocampal slice at a density of \~100 000 cells per slice. N9 cells were allowed to adhere to the slices for 15--20 min, and the unattached cells were washed away, leaving approximately 400--500 cells stuck at the slice surface. Voltage‐clamp recordings were obtained from CA3 pyramidal cells surrounded (10--100 μm) by three to five N9 cells in close vicinity. Excitatory postsynaptic currents (EPSCs) from MF--CA3 synapses were evoked by minimal‐intensity stimulation of MFs (Marchal & Mulle, [2004](#ejn13191-bib-0037){ref-type="ref"}; Sachidhanandam *et al*., [2009](#ejn13191-bib-0102){ref-type="ref"}). A glass electrode, with a tip diameter of \~1 μm, was placed on the hilus of the dentate gyrus to stimulate MFs. The baseline stimulation frequency for all experiments was 0.1 Hz. EPSCs were identified according to the following criteria: robust low‐frequency facilitation, low release probability at low stimulation (0.1 Hz), rapid rise time of individual EPSCs, and being free of secondary peaks during decay. LCCG‐1 (10 μ[m]{.smallcaps}), a metabotropic glutamate receptor 2 agonist, was added routinely to confirm the selective stimulation of MFs, and cells were excluded if the inhibition was \<80%. Pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid (PPADS), ivermectin, 5‐(3‐bromophenyl)‐1,3‐dihydro‐2*H*‐benzofuro\[3,2‐e\]‐1,4‐diazepin‐2‐one (5‐BDBD), apyrase, ARL67156 and SCH58261 were obtained from Tocris (Bristol, UK), and 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX) and 2‐chloro‐*N* ^6^‐cyclopentyladenosine (CCPA) were obtained from Abcam (Cambridge, UK). The antibody used for staining P2X~4~Rs (Ref. HPA039494) was obtained from Atlas Antibodies (Stockholm, Sweden).

Immunohistochemistry {#ejn13191-sec-0007}
--------------------

Mice (P19--P21) were anaesthetized by intraperitoneal administration of pentobarbital (50 mg/kg body weight), and were fixed by transcardial perfusion with 50 mL of 4% paraformaldehyde. Brains were removed and postfixed in 4% paraformaldehyde overnight, and then saturated in a solution with 30% sucrose for 24 h. They were then frozen in cold heptane, and stored at −80 °C. Brains were cut on a cryostat at −20 °C into 40‐μm‐thick coronal sections. Sections were collected into antifreeze medium, and stored at −20 °C. After a thorough wash in 0.1 [m]{.smallcaps} phosphate‐buffered saline (PBS) with 0.3% Triton X‐100 (PBST), free‐floating sections were incubated with 3% normal donkey serum (NDS) with 0.3% Triton X‐100 for 20 min at room temperature. Sections were then incubated overnight at 4 °C with the primary antibody anti‐P2X~4~R (1 : 400) in PBST--NDS solution. Slices were washed three times with 1 × PBS to rinse off the excess primary antibody before incubation for 2 h at room temperature with Alexa 488 goat anti‐rabbit (Synaptic Systems, Göttingen, Germany) at 1 : 400 in PBST--NDS solution. After being washed three times with 1 × PBS, slices were fixed with fluoromont medium containing 4′,6‐diamidino‐2‐phenylindole. Fluorescent images were acquired with a Leica DM6000 TCS SP8X microscope, with a diode laser (excitation -- blue, 405 nm; white, 488 nm; and emission -- green, 500--560 nm). Images were obtained by mosaic acquisition of the whole hippocampus at ×20.

Statistical analysis {#ejn13191-sec-0008}
--------------------

Values are presented as mean ± standard error of the mean (SEM), and *n* indicates the number of different cells. For statistical analysis, non‐parametric tests were used. Student\'s *t*‐test was used for comparison between two groups, and one‐way [anova]{.smallcaps} followed by a Newman--Keuls *post hoc* test for comparison between more than two groups. Statistical differences were considered to be significant at *P* \< 0.05. Note that, although the impacts of several drugs and modulators are presented as percentage values for the sake of clarity, statistical comparisons were always carried out with the absolute values. Statistical analysis was performed with [prism]{.smallcaps} 5.0 (GraphPad Software, La Jolla, CA, USA).

Results {#ejn13191-sec-0009}
=======

LPS‐treated microglia (LPS‐microglia) increase basal synaptic transmission at MF--CA3 synapses {#ejn13191-sec-0010}
----------------------------------------------------------------------------------------------

We first studied the effect of activated microglia on basal synaptic transmission. For this purpose, N9 microglia were first activated by pretreatment with LPS (100 ng/mL for 1 h) (Gomes *et al*., [2013](#ejn13191-bib-0023){ref-type="ref"}). Activated microglia were then added to acute hippocampal slices with previously described methodology (Centonze *et al*., [2009](#ejn13191-bib-0010){ref-type="ref"}). In our experimental condition, microglia fully covered the whole hippocampus and surrounded almost every CA3 pyramidal cell (Fig. [1](#ejn13191-fig-0001){ref-type="fig"}A and B). Although microglia do not penetrate deeply into the slice, we recorded CA3 pyramidal cells surrounded (10--100 μm) by an average of three to five microglia in close vicinity, i.e. similar to the estimated density of microglia in the CA3 area (Jinno *et al*., [2007](#ejn13191-bib-0025){ref-type="ref"}). Consistent with previous observations (Centonze *et al*., [2009](#ejn13191-bib-0010){ref-type="ref"}), no noticeable differences in morphology between non‐treated microglia (Fig. [1](#ejn13191-fig-0001){ref-type="fig"}A) and LPS‐microglia (Fig. [1](#ejn13191-fig-0001){ref-type="fig"}B) were observed. However, we have not carried out detailed morphological analysis to determine whether the physical interaction between LPS‐microglia and MF--CA3 synapses is similar to the interaction between endogenous microglia and MF--CA3 synapses.

![LPS‐microglia modulate short‐term synaptic plasticity via a microglial A~2~ ~A~R. (A) Non‐treated microglia added to an acute hippocampal slice. A CA3 pyramidal cell was recorded in the whole cell configuration of the patch clamp technique, and is surrounded by microglia (\*). Scale bar: 20 μm. (B) LPS‐microglia (\*) added to an acute hippocampal slice. Scale bar: 20 μm. (C) Representative traces of paired‐pulse recordings obtained at 40 ms intervals, under different conditions. (D) Representative traces of EPSCs recorded at 0.1 Hz and 1 Hz, illustrating FF in different conditions. (E) Graphical representation of the PPR in different conditions. SCH58261 (50 n[m]{.smallcaps}) was added for 20 min prior to activation of microglia by LPS (control, 392 ± 32%; microglia, 357 ± 35%; LPS‐microglia, 277 ± 31%; microglia + SCH58261, 336 ± 28%; LPS‐microglia + SCH58261, 324 ± 31%; *n* = 9 for all conditions). (F) Graphical representation of FF in different conditions (control, 482 ± 39%; microglia, 430 ± 18%; LPS‐microglia, 281 ± 18%; microglia + SCH58261, 375 ± 39%; LPS‐microglia + SCH58261, 373 ± 27%; *n* = 9 for all conditions). FF and PPR protocols were performed one after another, on the same cell. Data are represented as mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 from one‐way [anova]{.smallcaps} followed by a Newmann--Keuls multiple comparison test.](EJN-43-1366-g001){#ejn13191-fig-0001}

To study basal synaptic transmission, MF‐CA3 EPSCs (MF‐EPSCs) were evoked with a minimal stimulation protocol (Marchal & Mulle, [2004](#ejn13191-bib-0037){ref-type="ref"}). The average amplitude of MF‐EPSCs recorded at a low stimulation rate (0.1 Hz) (−73 ± 5 pA; *n* = 10) was consistent with previous observations (Marchal & Mulle, [2004](#ejn13191-bib-0037){ref-type="ref"}). The addition of non‐treated microglia had no effect on basal synaptic transmission (−76 ± 12 pA; *P* = 0.8, *n* = 9) whereas the addition of LPS‐microglia increased basal synaptic transmission (−106 ± 12 pA; *P* \< 0.05, *n* = 9; data not shown) (Table [1](#ejn13191-tbl-0001){ref-type="table-wrap"}).

###### 

Comparison of basal transmission (BT), PPF and FF with respect to control (slice alone)

  Compared to control   Microglia   LPS‐microglia   SCH58261‐microglia   Apyrase   ARL67156   DPCPX   CCPA   5‐BDBD   Ivermectin   P2X~4~ KO
  --------------------- ----------- --------------- -------------------- --------- ---------- ------- ------ -------- ------------ -----------
  BT                    --          ↑               --                   ↓         --         ↑       ↓      ↓        ↑            ↓
  PPF                   --          ↓               --                   --        --         --      --     ↓        --           ↓
  FF                    --          ↓               --                   --        ↓          --      ↓      --       ↓            --

For each experimental condition, values are normalized to control. ↑, increase; ↓, decrease; --, no effect.

John Wiley & Sons, Ltd

LPS‐microglia decrease short‐term plasticity at MF‐CA3 synapses {#ejn13191-sec-0011}
---------------------------------------------------------------

MF‐CA3 synapses are distinct from most other synapses in the central nervous system, because they show prominent forms of presynaptic short‐term plasticity (Nicoll & Schmitz, [2005](#ejn13191-bib-0043){ref-type="ref"}), including pronounced paired‐pulse facilitation (PPF) (two stimulations separated by 10--200 ms), represented by variation of the paired‐pulse ratio (PPR) (pulse 2/pulse 1), and frequency facilitation (FF) (tonic stimulation switching from 0.1 Hz to \>1 Hz). Activity‐dependent neurotransmitter release among central nervous system synapses depends largely on the basal release probability, which is linked to the presynaptic calcium concentration. Hence, PPF at MF‐CA3 synapses has been reported to depend solely on the residual calcium concentration in the presynaptic terminal (Salin *et al*., [1996](#ejn13191-bib-0055){ref-type="ref"}; Nicoll & Schmitz, [2005](#ejn13191-bib-0043){ref-type="ref"}). MF‐EPSCs recorded from slices with added LPS‐microglia showed decreased PPF, estimated from the PPR, as compared with slices with no added microglia (LPS‐microglia, 277 ± 31%; control, 392 ± 32%; *P* \< 0.05, *n* = 9; Fig. [1](#ejn13191-fig-0001){ref-type="fig"}C and E) and slices with non‐treated microglia added (microglia, 357 ± 35%, *n* = 9; Fig. [1](#ejn13191-fig-0001){ref-type="fig"}C and E). Added LPS‐microglia also significantly decreased FF as compared with control (LPS‐microglia, 281 ± 18%; control, 482 ± 39%; *P* \< 0.001, *n* = 9; Fig. [1](#ejn13191-fig-0001){ref-type="fig"}D and F) and slices with non‐treated microglia added (microglia, 430 ± 18%; *P* \< 0.05, *n* = 9; Fig. [1](#ejn13191-fig-0001){ref-type="fig"}D and F). As both PPF and FF were similar between control slices and slices with added non‐treated microglia, our results indicated that the decrease in short‐term plasticity observed with added LPS‐microglia was probably attributable to the immune challenging of microglia.

Inhibition of microglial A~2A~Rs prevents changes in short‐term plasticity {#ejn13191-sec-0012}
--------------------------------------------------------------------------

The immune challenging of microglia with LPS (100 ng/mL) is known to drive microglia to release ATP, and this is abolished by blocking adenosine A~2A~Rs on microglia (Gomes *et al*., [2013](#ejn13191-bib-0023){ref-type="ref"}; George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}). We thus hypothesized that ATP released from LPS‐microglia was involved in the observed changes in short‐term synaptic plasticity. Taking advantage of the fact that neuronal presynaptic A~2A~Rs do not, as such, modulate basal synaptic transmission or either PPF or FF at MF synapses (Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}), we antagonized A~2A~Rs on microglia by pre‐incubation with the A~2A~R antagonist SCH58261 (50 n[m]{.smallcaps}) for 20 min (Lopes *et al*., [2004](#ejn13191-bib-0036){ref-type="ref"}) prior to activation of microglia by LPS and addition to acute slices.

The pre‐incubation of LPS‐microglia with SCH58261 significantly reduced the decrease in FF induced by the addition of LPS‐microglia (LPS‐microglia, 281 ± 18%; LPS‐microglia + SCH58261, 373 ± 27%; *P* \< 0.05, *n* = 9) (Fig. [1](#ejn13191-fig-0001){ref-type="fig"}F) but had no significant effect on the decrease in PPF (LPS‐microglia, 277 ± 31%; LPS‐microglia + SCH58261, 324 ± 31%; *P* = 0.65, *n* = 9) (Fig. [1](#ejn13191-fig-0001){ref-type="fig"}E; Table [2](#ejn13191-tbl-0002){ref-type="table-wrap"}). Thus, the blockade of A~2A~Rs in LPS‐microglia alleviated some of the changes observed in MF‐CA3 short‐term synaptic plasticity. As we have previously shown that A~2A~Rs control ATP release from microglia (George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}), this supports the hypothesis that ATP released from LPS‐microglia might impact on MF‐CA3 synaptic activity, leading to changes in short‐term synaptic plasticity.

###### 

Comparison of basal transmission (BT), PPF and FF with respect to LPS‐microglia (slice + LPS‐microglia)

  Compared to LPS‐microglia   SCH58261   Apyrase   DPCPX   CCPA   5‐BDBD   P2X~4~ KO
  --------------------------- ---------- --------- ------- ------ -------- -----------
  BT                          ↓          ↓         ↑       ↓      ↓        ↓
  PPF                         --         ↑         ↑       --     --       ↑
  FF                          ↑          ↑         --      --     ↑        --

For each experimental condition, values are normalixed to LPS‐microglia. ↑, increase; ↓, decrease; --, no effect.

John Wiley & Sons, Ltd

LPS‐microglia regulate FF {#ejn13191-sec-0013}
-------------------------

To further validate the putative role of ATP, released by LPS‐microglia, in the observed changes in FF and PPF, we manipulated extracellular ATP by either promoting its degradation with apyrase or by blocking its extracellular degradation with ARL67156 (Frenguelli *et al*., [2007](#ejn13191-bib-0020){ref-type="ref"}). Addition of apyrase (10 U/mL) decreased basal synaptic transmission at low frequency (0.1 Hz) within 5 min (control, 98 ± 1%; apyrase, 54 ± 1%; *P* \< 0.001, *n* = 4) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}A and B). In addition, apyrase abolished the decrease in FF induced by LPS‐microglia (LPS‐microglia, 281 ± 18%; LPS‐microglia + apyrase, 393 ± 24%; *P* \< 0.01, *n* = 4) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}E). Apyrase also abolished the decrease in PPF induced by LPS‐microglia (LPS‐microglia, 277 ± 31%; LPS‐microglia + apyrase, 466 ± 86%; *P* \< 0.05, *n* = 4) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}F). Conversely, ARL67156 was used in control slices (no microglia added) to determine whether increasing the endogenous levels of ATP in control conditions could mimic the alterations induced by LPS‐microglia. ARL67156 (100 μ[m]{.smallcaps}) alone did not significantly affect the amplitude of MF‐EPSCs recorded at 0.1 Hz (control, 98 ± 1%; ARL67156, 115 ± 13%; *P* = 0.2, *n* = 4) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}C and D), but reduced FF as LPS‐microglia did (control, 482 ± 39%; ARL67156, 183 ± 27%, *P* \< 0.001; LPS‐microglia, 281 ± 18%, *P* \< 0.001, *n* = 4) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}G). In contrast, ARL67156 did not significantly affect PPF (control, 392 ± 32%; ARL67156, 374 ± 71%; *P* = 0.3, *n* = 3) (Fig. [2](#ejn13191-fig-0002){ref-type="fig"}H).

![LPS‐microglia‐derived ATP modulates synaptic transmission and short‐term plasticity. (A) Summary plot of the effect of apyrase on basal synaptic transmission recorded at low frequency of stimulation (0.1 Hz). Apyrase (10 U/mL) induced a decrease in basal synaptic transmission as measured by the amplitude of EPSCs (control, black squares; apyrase, open squares). (B) Graphical representation of the basal synaptic transmission shown in A (control, 98 ± 1%, *n* = 9; apyrase, 54 ± 1%, *n* = 4). (C) Summary plot of the effect of ARL67156 (100 μ[m]{.smallcaps}) on basal synaptic transmission recorded at low frequency of stimulation (0.1 Hz). ARL67156 did not significantly affect the amplitude of MF‐EPSCs within 10 min of addition (*n* = 4) (control, black squares; ARL67156, open squares). LCCG‐1 (10 μ[m]{.smallcaps}), a metabotropic glutamate receptor 2 agonist, was added to confirm the selective stimulation of MFs. (D) Graphical representation of the basal synaptic transmission shown in C (control, 98 ± 1%, *n* = 9; ARL67156, 115 ± 13%, *n* = 4). (E) Graphical representation of FF. Apyrase abolished the effect of LPS‐microglia on FF (control, 482 ± 39%, *n* = 9; apyrase, 444 ± 69%, *n* = 4; LPS‐microglia, 281 ± 18%, *n* = 9; LPS‐microglia + apyrase, 393 ± 24%, *n* = 4). (F) Graphical representation of PPR. Apyrase abolished the reduction in PPR induced by LPS‐microglia (control, 392 ± 32%, *n* = 9; apyrase, 301 ± 34%, *n* = 4; LPS‐microglia, 277 ± 31%, *n* = 9; LPS‐microglia + apyrase, 466 ± 86%, *n* = 4). (G) Graphical representation of FF. Addition of ARL67156 (100 μ[m]{.smallcaps}) mimicked the LPS‐microglia‐induced decrease in FF (control, 482 ± 39%, *n* = 9; LPS‐microglia, 281 ± 18%, *n* = 9; ARL67156, 183 ± 27%, *n* = 3). (H) Graphical representation of PPR. Increasing the extracellular level of ATP with ARL67156 (100 μ[m]{.smallcaps}) had no effect on PPR (control, 392 ± 32%, *n* = 9; LPS‐microglia, 277 ± 31%, *n* = 9; ARL67156, 374 ± 71%, *n* = 3). Values in all graphs are mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 from one‐way [anova]{.smallcaps} followed by a Newmann--Keuls multiple comparison test.](EJN-43-1366-g002){#ejn13191-fig-0002}

Hence, the decrease in FF induced by LPS‐microglia was abolished by removal of extracellular ATP, whereas this decrease was mimicked by increased endogenous levels of ATP in control slices. In contrast, modulation of extracellular ATP did not have a significant effect on PPF; that is, manipulating the extracellular levels of ATP did not mimic or abolish the effects of LPS‐microglia.

Adenosine is involved in LPS‐microglia‐mediated regulation of PPF {#ejn13191-sec-0014}
-----------------------------------------------------------------

Our data strongly suggest that ATP is the key molecule responsible for the microglia‐induced changes in presynaptic forms of short‐term plasticity. However, ATP is readily converted into adenosine by extracellular ectonucleotidases (Cunha *et al*., [1998](#ejn13191-bib-0014){ref-type="ref"}), namely in synapses (Cunha, [2001](#ejn13191-bib-0013){ref-type="ref"}), and presynaptic adenosine A~1~Rs are present at MF--CA3 synapses (Scanziani *et al*., [1992](#ejn13191-bib-0056){ref-type="ref"}; Moore *et al*., [2003](#ejn13191-bib-0039){ref-type="ref"}; Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}; Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}). Therefore, we investigated whether adenosine derived from the ATP released by LPS‐microglia could modulate MF--CA3 transmission.

We first studied the effects of CCPA (A~1~R agonist) and of DPCPX \[A~1~R antagonist; see Sebastião *et al*. ([2000](#ejn13191-bib-0057){ref-type="ref"})\] on FF. As shown in Fig. [3](#ejn13191-fig-0003){ref-type="fig"}B, DPCPX (100 n[m]{.smallcaps}) alone did not significantly change FF (control, 482 ± 39%; DPCPX, 426 ± 87%; *P* = 0.5, *n* = 9), in agreement with previous studies (Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}; Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}) \[but see Moore *et al*. ([2003](#ejn13191-bib-0039){ref-type="ref"})\], and also had no effect on basal synaptic transmission (control, 147 ± 18%; DPCPX, 97 ± 3%; *P* = 0.06, *n* = 9; data not shown). DPCPX did not abolish the LPS‐microglia‐induced decrease in FF (LPS‐microglia, 281 ± 18%; LPS‐microglia + DPCPX, 250 ± 38%; *P* = 0.8, *n* = 9) (Fig. [3](#ejn13191-fig-0003){ref-type="fig"}B). Furthermore, CCPA (100 n[m]{.smallcaps}) did not mimic the effect of LPS‐microglia on FF (CCPA, 399 ± 52%; LPS‐microglia, 281 ± 18%; *P* = 0.08, *n* = 9) (Fig. [3](#ejn13191-fig-0003){ref-type="fig"}D). Finally, CCPA did not alter the LPS‐microglia‐induced decrease in FF (LPS‐microglia, 281 ± 18%; LPS‐microglia + CCPA, 230 ± 42%; *P* = 0.2, *n* = 9) (Fig. [3](#ejn13191-fig-0003){ref-type="fig"}D). In contrast, DPCPX prevented the change in PPF induced by LPS‐microglia (LPS‐microglia, 277 ± 31%; LPS‐microglia + DPCPX, 383 ± 35%, *P* \> 0.05, *n* = 9) (Fig. [3](#ejn13191-fig-0003){ref-type="fig"}C). Conversely, CCPA decreased PPF when added to control slices (control, 392 ± 32%; CCPA, 269 ± 38%; *P* \> 0.05, *n* = 9) (Fig. [3](#ejn13191-fig-0003){ref-type="fig"}E), mimicking the effect of LPS‐microglia.

![LPS‐microglia‐induced modulation of PPF involves adenosine and presynaptic A~1~Rs. (A) Representative traces of EPSCs triggered at a low frequency of stimulation (0.1 Hz). (B) Graphical representation of FF. Blockade of A~1~Rs by DPCPX (100 n[m]{.smallcaps}) had no effect on the LPS‐microglia‐induced change in FF (control, 482 ± 39%; DPCPX, 426 ± 87%; microglia, 430 ± 18%; microglia + DPCPX, 367 ± 41%; LPS‐microglia, 281 ± 18%; LPS‐microglia + DPCPX, 250 ± 38%; *n* = 9 for all conditions). (C) Graphical representation of the PPR. Blockade of A~1~Rs inhibited the reduction in the PPR induced by LPS‐microglia (control, 392 ± 32%; DPCPX, 326 ± 18%; microglia, 357 ± 35%; microglia + DPCPX, 333 ± 29%; LPS‐microglia, 277 ± 31%; LPS‐microglia + DPCPX, 383 ± 35%; *n* = 9 for all conditions). (D) Graphical representation of FF. CCPA (100 n[m]{.smallcaps}) did not alter the LPS‐microglia‐induced decrease in FF (control, 482 ± 39%; CCPA, 399 ± 52%; microglia, 430 ± 18%; microglia + CCPA, 382 ± 48%; LPS‐microglia, 281 ± 18%; LPS‐microglia + CCPA, 230 ± 42%; *n* = 9 for all conditions). (E) Graphical representation of the PPR. CCPA decreased the PPR, mimicking the effect of LPS‐microglia (control, 392 ± 32%; CCPA, 269 ± 38%; microglia, 357 ± 35%; microglia + CCPA, 270 ± 25%; LPS‐microglia, 277 ± 31%; LPS‐microglia + CCPA, 259 ± 37%; *n* = 9 for all conditions). Values in all graphs are mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 from one‐way [anova]{.smallcaps} followed by a Newmann--Keuls multiple comparison test.](EJN-43-1366-g003){#ejn13191-fig-0003}

Taken together, these results indicate that the level of extracellular adenosine in our experimental conditions was moderate, as estimated by the lack of a significant effect of DPCPX on basal synaptic transmission, and show that, whereas adenosine produced by the breakdown of released ATP from LPS‐microglia has no effect on FF, it modulates PPF.

P2X~4~Rs modulate short‐term synaptic plasticity {#ejn13191-sec-0015}
------------------------------------------------

To further characterize the role of ATP derived from LPS‐microglia in the modulation of FF, we investigated which subtype of purinergic receptor was involved. ATP can bind to metabotropic (P2Y) and ionotropic (P2X) receptors. A role of P2X receptors has been reported in hippocampal synapses, mostly in the context of synaptic plasticity (Soto *et al*., [1996](#ejn13191-bib-0059){ref-type="ref"}; Khakh *et al*., [1999](#ejn13191-bib-0029){ref-type="ref"}; Pankratov *et al*., [2002](#ejn13191-bib-0044){ref-type="ref"}; Priel & Silberberg, [2004](#ejn13191-bib-0047){ref-type="ref"}; Sim *et al*., [2006](#ejn13191-bib-0058){ref-type="ref"}; Pougnet *et al*., [2014](#ejn13191-bib-0046){ref-type="ref"}). As shown in Fig. [4](#ejn13191-fig-0004){ref-type="fig"}A, the effect of LPS‐microglia on FF was prevented by blocking P2X receptors with the broad‐spectrum antagonist PPADS (50 μ[m]{.smallcaps}) (Lambrecht *et al*., [2002](#ejn13191-bib-0034){ref-type="ref"}) (LPS‐microglia, 281 ± 18%; LPS‐microglia + PPADS, 427 ± 56%; *P* \> 0.05, *n* = 9). In contrast, PPADS had no effect on the decrease in PPF induced by LPS‐microglia (LPS‐microglia, 277 ± 31%; LPS‐microglia + PPADS, 281 ± 22%; *P* = 0.9, *n* = 9) (Fig. [4](#ejn13191-fig-0004){ref-type="fig"}B). These results provide evidence that P2X receptors specifically modulated FF, and not PPF.

![Extracellular ATP modulates basal synaptic transmission and FF via presynaptic P2X~4~Rs. (A) Graphical representation of FF. PPADS (50 μ[m]{.smallcaps}) blocked the LPS‐microglia‐induced decrease in FF (control, 482 ± 39%; LPS‐microglia, 281 ± 18%; LPS‐microglia + PPADS, 427 ± 56%; *n* = 9 for all conditions). (B) Graphical representation of PPR. PPADS (50 μ[m]{.smallcaps}) had no effect on the LPS‐microglia‐induced decrease in PPR (control, 392 ± 32%; LPS‐microglia, 277 ± 31%; LPS‐microglia + PPADS, 281 ± 22%; *P* = 0.9, *n* = 9 for all conditions). (C) Summary plot of the effect of 5‐BDBD (10 μ[m]{.smallcaps}) on basal synaptic transmission. 5‐BDBD induced a decrease in basal synaptic transmission within 5 min of addition (control, black squares; 5‐BDBD, open squares). (D) Graphical representation of the basal synaptic transmission shown in C (control, 98 ± 1%; 5‐BDBD, 65 ± 4%; *n* = 9 for both conditions). (E) Summary plot of the effect of ivermectin (3 μ[m]{.smallcaps}) on basal synaptic transmission. Ivermectin increased basal synaptic transmission within 10 min of addition (control, black squares; ivermectin, open squares). (F) Graphical representation of the basal synaptic transmission shown in E (control, 98 ± 1%, *n* = 9; ivermectin, 128 ± 7%, *n* = 6). The values in A, B, D and F are mean ± SEM; \**P* \< 0.05 and \*\*\**P* \< 0.001, unpaired *t*‐test. (G) Graphical representation of FF. Ivermectin (3 μ[m]{.smallcaps}) decreased FF, whereas 5‐BDBD (10 μ[m]{.smallcaps}) had no effect (control, 482 ± 39%, *n* = 9; ivermectin, 344 ± 35%, *n* = 6; 5‐BDBD, 438 ± 25%, *n* = 9). (H) Graphical representation of PPR. 5‐BDBD (10 μ[m]{.smallcaps}) decreased PPR, whereas ivermectin (3 μ[m]{.smallcaps}) had no effect (control, 392 ± 32%, *n* = 9; ivermectin, 369 ± 40%, *n* = 6; 5‐BDBD, 227 ± 16%, *n* = 9). The values in G and H are mean ± SEM; \**P* \< 0.05 and \*\**P* \< 0.01 from one‐way [anova]{.smallcaps} followed by a Newmann--Keuls multiple comparison test. (I) The hippocampal MFs showed strong immunostaining for P2X~4~R (green) in a wild‐type (WT) mouse (upper panel), whereas it was virtually absent in a slice from a P2X~4~R KO mouse (lower panel). 4′,6‐Diamidino‐2‐phenylindole staining for nuclei is shown in blue. Scale bar: 200 μm.](EJN-43-1366-g004){#ejn13191-fig-0004}

We next investigated which subtype of P2X receptor was responsible for the effect of LPS‐microglia on FF. The presynaptic expression of P2X~7~Rs at MFs remains controversial (Armstrong *et al*., [2002](#ejn13191-bib-0003){ref-type="ref"}; Sperlágh *et al*., [2002](#ejn13191-bib-0103){ref-type="ref"}; Kukley *et al*., [2004](#ejn13191-bib-0032){ref-type="ref"}; Yu *et al*., [2008](#ejn13191-bib-0066){ref-type="ref"}), whereas the involvement of P2X~4~Rs in the modulation of synaptic strength (Baxter *et al*., [2011](#ejn13191-bib-0004){ref-type="ref"}) and/or plasticity has been documented (Sim *et al*., [2006](#ejn13191-bib-0058){ref-type="ref"}) at CA3--CA1 synapses. However, the presence of P2X~4~Rs at MF synapses remains to be studied. We first investigated whether P2X~4~Rs were involved in the modulation of basal synaptic transmission. Application of the selective P2X~4~R antagonist 5‐BDBD (10 μ[m]{.smallcaps}) (Donnelly‐Roberts *et al*., [2008](#ejn13191-bib-0017){ref-type="ref"}) decreased basal synaptic transmission at low frequency (0.1 Hz) within 5 min of its addition (control, 98 ± 1%; 5‐BDBD, 65 ± 4%; *P* \< 0.001, *n* = 9) (Fig. [4](#ejn13191-fig-0004){ref-type="fig"}C and D). Conversely, ivermectin (3 μ[m]{.smallcaps}), a positive allosteric modulator of P2X~4~Rs that potentiates P2X~4~R currents (Khakh *et al*., [1999](#ejn13191-bib-0029){ref-type="ref"}; Sim *et al*., [2006](#ejn13191-bib-0058){ref-type="ref"}), increased basal synaptic transmission at low frequency (0.1 Hz) within 10 min of its addition (control, 98 ± 1%; ivermectin, 128 ± 7%; *P* \< 0.05, *n* = 6) (Fig. [4](#ejn13191-fig-0004){ref-type="fig"}E and F). Consistent with these results, basal synaptic transmission was also decreased in slices obtained from P2X~4~R knockout (KO) mice (control, 98 ± 1%; P2X~4~R KO, 85 ± 6%; *P* \< 0.05, *n* = 9; data not shown). Therefore, ATP modulates basal synaptic transmission at MF‐CA3 synapses through P2X~4~Rs.

We then investigated the putative role of P2X~4~Rs in the modulation of FF. Selective blockade of P2X~4~Rs with 5‐BDBD on its own had no effect on FF (control, 482 ± 39%; 5‐BDBD, 438 ± 25%; *P* = 0.12, *n* = 9), whereas potentiation of P2X~4~Rs by ivermectin significantly decreased FF (control, 482 ± 39%; ivermectin, 344 ± 35%; *P* \< 0.05, *n* = 9) (Fig. [4](#ejn13191-fig-0004){ref-type="fig"}G). Conversely, 5‐BDBD on its own decreased PPF (control, 392 ± 32%; 5‐BDBD, 227 ± 16%; *P* \< 0.01, *n* = 9), whereas ivermectin had no effect (control, 392 ± 32%; ivermectin, 369 ± 40%; *P* = 0.66, *n* = 9) (Fig. [4](#ejn13191-fig-0004){ref-type="fig"}H).

These results provide good evidence that activation of P2X~4~Rs modulates FF but not PPF, and suggest a presynaptic site of action for ATP. To further strengthen the hypothesis of presynaptic localization of P2X~4~Rs, we used a new antibody raised against P2X~4~Rs and checked its specificity in slices from P2X~4~R KO mice. As shown in Fig. [4](#ejn13191-fig-0004){ref-type="fig"}I, we observed strong immunostaining for P2X~4~R (green) on the MF tract (upper panel) that was almost completely absent in slices from P2X~4~R KO mice (lower panel). It is worth noting that we did not observe clear P2X~4~R immunoreactivity in the CA1 area, in contrast to previous reports (Rubio & Soto, [2001](#ejn13191-bib-0101){ref-type="ref"}; Sim *et al*., [2006](#ejn13191-bib-0058){ref-type="ref"}), suggesting the possibility that different antibodies may recognize different known molecular structures of homomeric P2X~4~Rs (Zemkova *et al*., [2015](#ejn13191-bib-0067){ref-type="ref"}), different known heteromeric receptor complexes containing P2X~4~R subunits (Antonio *et al*., [2014](#ejn13191-bib-0002){ref-type="ref"}), or P2X~4~Rs with different subcellular localizations (Xu *et al*., [2014](#ejn13191-bib-0065){ref-type="ref"}).

P2X~4~Rs mediate the LPS‐microglia‐induced decrease in FF {#ejn13191-sec-0016}
---------------------------------------------------------

We then investigated the possible involvement of P2X~4~Rs in the modulation of FF by LPS‐microglia. Blockade of P2X~4~Rs in hippocampal slices before the addition of LPS‐microglia prevented the decrease in FF (LPS‐microglia + 5‐BDBD, 378 ± 28%; LPS‐microglia, 281 ± 18%; *P* \< 0.01, *n* = 9) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}B) but did not alleviate the decrease in PPF (LPS‐microglia + 5‐BDBD, 242 ± 25%; LPS‐microglia, 277 ± 31%; *P* = 0.09, *n* = 9) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}C). Because P2X~4~Rs are also dynamically involved in controlling endogenous microglia (Toulme & Khakh, [2012](#ejn13191-bib-0060){ref-type="ref"}; Koizumi *et al*., [2013](#ejn13191-bib-0031){ref-type="ref"}) as well as N9 microglia (Xiang & Burnstock, [2005](#ejn13191-bib-0064){ref-type="ref"}), we investigated whether the effect of 5‐BDBD was attributable to P2X~4~Rs expressed at MF‐CA3 synapses or those expressed by N9 microglia added to the slice. For this purpose, LPS‐microglia were added to hippocampal slices obtained from P2X~4~R KO mice.

![LPS‐microglia‐derived ATP regulates FF via P2X~4~Rs. (A) Representative traces of EPSCs triggered at low frequency of stimulation (0.1 Hz). (B) Graphical representation of FF. Blockade of P2X~4~Rs by 5‐BDBD (10 μ[m]{.smallcaps}) inhibited the effect of LPS‐microglia on FF (control, 482 ± 39%; 5‐BDBD, 438 ± 25%; microglia, 430 ± 18%; microglia + 5‐BDBD, 374 ± 35%; LPS‐microglia, 281 ± 18%; LPS‐microglia + 5‐BDBD, 378 ± 28%; *n* = 9 for all conditions). (C) Graphical representation of the PPR. 5‐BDBD (10 μ[m]{.smallcaps}) had no effect on the decrease in the PPR induced by LPS‐microglia, whereas it reduced it when applied alone (control, 392 ± 32%; 5‐BDBD, 227 ± 16%; microglia, 357 ± 35%; microglia + 5‐BDBD, 212 ± 18%; LPS‐microglia, 277 ± 31%; LPS‐microglia + 5‐BDBD, 242 ± 25%; *n* = 9 for all conditions). (D) Bar representation of FF. Genetic deletion of P2X~4~R (P2X~4~R KO) abolished the LPS‐microglia induced decrease in FF (control, 482 ± 39%; P2X~4~R KO, 419 ± 43%; microglia, 430 ± 18%; microglia + P2X~4~R KO, 377 ± 31%; LPS‐microglia, 281 ± 18%; LPS‐microglia + P2X~4~R KO, 337 ± 23%; *n* = 9 for all conditions). (E) Graphical representation of the PPR. The LPS‐microglia‐induced decrease in the PPR was preserved in P2X~4~R KO slices (control, 392 ± 32%; P2X~4~R KO, 253 ± 32%; microglia, 357 ± 35%; microglia + P2X~4~R KO, 216 ± 57%; LPS‐microglia, 277 ± 31%; LPS‐microglia + P2X~4~R KO, 265 ± 41%; *n* = 9 for all conditions). (F) Graphical representation of FF. Addition of ARL67156 (10 μ[m]{.smallcaps}) mimicked the LPS‐microglia‐induced decrease in FF, whereas prior blockade of P2X~4~Rs by 5‐BDBD (10 μ[m]{.smallcaps}) prevented this effect (control, 482 ± 39%, *n* = 9; ARL67156, 183 ± 29%, *n* = 3; LPS‐microglia, 281 ± 18%, *n* = 9; ARL67156 + 5‐BDBD, 442 ± 97%, *n* = 3). (G) Graphical representation of the PPR. Increasing the level of endogenous ATP with ARL67156 (10 μ[m]{.smallcaps}) had no effect on the PPR (control, 392 ± 32%, *n* = 9; ARL67156, 324 ± 71%, *n* = 3; LPS‐microglia, 277 ± 31%, *n* = 9; ARL67156 + 5‐BDBD, 281 ± 78%, *n* = 3). Values in all graphs are mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 from one‐way [anova]{.smallcaps} followed by a Newmann--Keuls multiple comparison test.](EJN-43-1366-g005){#ejn13191-fig-0005}

The decrease in FF induced by LPS‐microglia was reduced in slices obtained from P2X~4~R KO mice (LPS‐microglia + P2X~4~R KO, 337 ± 23%; LPS‐microglia, 281 ± 18%; *P* \< 0.05, *n* = 6) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}D), whereas the decrease in PPF induced by LPS‐microglia was preserved in slices from P2X~4~R KO mice (LPS‐microglia + P2X~4~R KO, 265 ± 41%; LPS‐microglia, 277 ± 31%; *P* = 0.8, *n* = 9) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}E).

The ectonucleotidase inhibitor ARL67156 (10 μ[m]{.smallcaps}) mimicked the LPS‐microglia‐induced decrease in FF (control, 482 ± 39%, *n* = 9; LPS‐microglia, 281 ± 18%; *P* \< 0.001, *n* = 9; ARL67156, 183 ± 29%; *P* \< 0.001, *n* = 3) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}F), whereas prior blockade of P2X~4~Rs by 5‐BDBD (10 μ[m]{.smallcaps}) prevented this effect (ARL67156 + 5‐BDBD, 442 ± 97%; *P* \< 0.02, *n* = 3) (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}F). In contrast, prior blockade of P2X~4~Rs by 5‐BDBD, before addition of ARL67156, had no further effect on PPF (Fig. [5](#ejn13191-fig-0005){ref-type="fig"}G).

ATP and adenosine modulate synaptic plasticity independently of each other {#ejn13191-sec-0017}
--------------------------------------------------------------------------

Our data strongly suggest that extracellular ATP released from LPS‐microglia acts on P2X~4~Rs to modulate FF, and that adenosine catabolized from extracellular ATP acts on A~1~Rs to modulate PPF. Adenosine being the end‐product of ATP, we had to disentangle any possible indirect effects of ATP on PPF or adenosine on FF. For this purpose, FF and PPF were investigated in the presence of DPCPX in slices obtained from P2X~4~R KO mice. The LPS‐microglia‐induced decrease in FF (Fig. [6](#ejn13191-fig-0006){ref-type="fig"}A and B) was reduced in P2X~4~R KO mice (LPS‐microglia, 281 ± 18%; LPS‐microglia + P2X~4~R KO, 337 ± 23%; *P* \< 0.05, *n* = 9), but was preserved in the presence of DPCPX (LPS‐microglia + P2X~4~R KO + DPCPX, 402 ± 38%; *P* \< 0.001, *n* = 5) (Fig. [6](#ejn13191-fig-0006){ref-type="fig"}B). This indicates that A~1~Rs have no effect on the modulation of FF by P2X~4~Rs. Conversely, genetic deletion of P2X~4~Rs did not prevent the ability of DPCPX to block the LPS‐microglia‐induced decrease in PPF (Fig. [6](#ejn13191-fig-0006){ref-type="fig"}C and D). Hence, ATP released by LPS‐microglia and its end‐product adenosine act independently on P2X~4~Rs and A~1~Rs, respectively, to modulate short‐term synaptic plasticity.

![ATP and adenosine act independently on P2X~4~Rs and A~1~Rs. (A) Representative traces of EPSCs recorded at 0.1 Hz and 1 Hz, illustrating FF in different conditions. (a) Control. (b) LPS‐microglia. (c) LPS‐microglia + P2X~4~R KO. (d) LPS‐microglia + P2X~4~R KO + DPCPX. (B) Graphical representation of FF. Blockade of A~1~R by DPCPX (100 n[m]{.smallcaps}) had no effect on the inhibitory effect of P2X~4~R KO on the LPS‐microglia‐induced change in FF (control, 482 ± 39%, *n* = 9; P2X~4~R KO + DPCPX, 434 ± 98%, *n* = 5; LPS‐microglia, 281 ± 18%, *n* = 9; LPS‐microglia + P2X~4~R KO, 337 ± 23%, *n* = 9; LPS‐microglia + P2X~4~R KO + DPCPX, 402 ± 38%, *n* = 5). (C) Representative traces of EPSCs recorded at 0.1 Hz, illustrating the PPR in different conditions. (a) Control. (b) LPS‐microglia. (c) LPS‐microglia + DPCPX. (d) LPS‐microglia + P2X~4~R KO + DPCPX. (D) Graphical representation of the PPR. Genetic deletion of P2X~4~Rs had no effect on the DPCPX‐induced inhibition of the LPS‐microglia‐induced decrease in the PPR (control, 392 ± 32%, *n* = 9; P2X~4~R KO + DPCPX, 388 ± 66%, *n* = 5; LPS‐microglia, 277 ± 31%, *n* = 9; LPS‐microglia + DPCPX, 383 ± 35%, *n* = 9; LPS‐microglia + P2X~4~R KO + DPCPX, 417 ± 36%, *n* = 5). Values in all graphs are mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 and \*\*\**P* \< 0.001 from one‐way [anova]{.smallcaps} followed by a Neumann--Keuls multiple comparison test.](EJN-43-1366-g006){#ejn13191-fig-0006}

Discussion {#ejn13191-sec-0018}
==========

Over the last 10 years, the notion of microglia as passive sentinels within the brain has been noticeably widened, and microglia are now acknowledged to constitute a new partner in synaptic function (Tremblay *et al*., [2010](#ejn13191-bib-0061){ref-type="ref"}) \[reviewed in Kettenmann *et al*. ([2013](#ejn13191-bib-0028){ref-type="ref"})\]. Indeed, microglia can secrete a full array of neuroactive molecules, including several proinflammatory cytokines (interleukin‐1β, interleukin‐6, and tumour necrosis factor‐α), trophic factors such as brain‐derived neurotrophic factor, and also neurotransmitters such as ATP, glycine, and glutamate \[reviewed in Kettenmann *et al*. ([2011](#ejn13191-bib-0027){ref-type="ref"})\]. In the present study, we focused on the putative effect of microglia‐derived purines on synaptic function at MF‐CA3 synapses. In this experimental paradigm, N9 microglia were previously challenged with an immune stimulus (LPS) to induce them to release ATP (George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}), and were then added to hippocampal slices.

Combining pharmacological, electrophysiological and immunohistochemical approaches, our study demonstrated that ATP released by LPS‐microglia modulates MF‐CA3 synaptic transmission both directly via presynaptic P2X~4~Rs and through its metabolite adenosine, by acting on presynaptic A~1~Rs. Each pathway selectively modulates a different type of short‐term presynaptic plasticity at MF‐CA3 synapses, namely FF for P2X~4~Rs and PPF for A~1~Rs. This study reveals complex crosstalk between microglial release of ATP, purinergic receptor activation, and hippocampal synaptic function.

P2X~4~Rs modulate basal synaptic transmission {#ejn13191-sec-0019}
---------------------------------------------

Basal synaptic transmission at MF‐CA3 synapses is governed by presynaptic intracellular calcium homeostasis and cAMP levels (Nicoll & Schmitz, [2005](#ejn13191-bib-0043){ref-type="ref"}). Within the ionotropic P2X receptor family, P2X~4~Rs show the highest permeability for calcium (Soto *et al*., [1996](#ejn13191-bib-0059){ref-type="ref"}; Burnstock *et al*., [2011](#ejn13191-bib-0008){ref-type="ref"}), and, through this property, P2X~4~Rs can modulate basal synaptic transmission. In good agreement with this, the blockade of P2X~4~Rs by 5‐BDBD or their genetic deletion in P2X~4~R KO mice decreased basal synaptic transmission, whereas ivermectin, which selectively potentiates ATP‐induced currents at P2X~4~Rs (Khakh *et al*., [1999](#ejn13191-bib-0029){ref-type="ref"}; Priel & Silberberg, [2004](#ejn13191-bib-0047){ref-type="ref"}), increased it. As expected, the degradation of extracellular ATP by apyrase also decreased basal synaptic transmission. All together, these results suggest that extracellular ATP tonically modulates basal synaptic transmission, most likely by increasing the presynaptic calcium concentration via its influx through P2X~4~Rs.

Interestingly, the end‐product of ATP catabolism, i.e. adenosine, by acting on presynaptic A~1~Rs, also tonically decreases basal synaptic transmission (Moore *et al*., [2003](#ejn13191-bib-0039){ref-type="ref"}; Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}; Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}), probably through the direct A~1~R inhibition of calcium influx via presynaptic P/Q‐type and N‐type calcium channels (Gundlfinger *et al*., [2007](#ejn13191-bib-0024){ref-type="ref"}). Our results suggest that purines modulate basal synaptic transmission via a complex interplay between ATP and adenosine signalling, which produce opposite effects.

Microglia‐derived ATP impacts on FF {#ejn13191-sec-0020}
-----------------------------------

Owing to their unusual low initial glutamate release probability, MF‐CA3 synapses show a large facilitation of response amplitudes of up to 500--600% when the frequency of stimulation is increased from 0.1 Hz to 1 Hz. This unique form of short‐term plasticity, termed FF, was decreased by 40--50% following the addition of LPS‐microglia. Several lines of evidence clearly demonstrate that ATP produced by LPS‐microglia and acting on P2X~4~Rs was responsible for this effect: first, the addition of unstimulated microglia to acute slices had no effect on FF; second, the decrease in FF following the addition of LPS‐microglia was prevented by apyrase but potentiated by ARL67156; third, it was blocked by PPADS, a broad‐spectrum P2X receptor antagonist, but also by 5‐BDBD; fourth, it was mimicked by ivermectin; fifth, it was absent in P2X~4~R KO mice; and sixth, it was insensitive to the A~1~R ligands DPCPX (antagonist) and CCPA (agonist), in agreement with previous work (Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}).

It is not known for certain how FF is governed at MF‐CA3 synapses, and different mechanisms have been proposed, such as the involvement of calcium/calmodulin‐dependent protein kinase II (Salin *et al*., [1996](#ejn13191-bib-0055){ref-type="ref"}), presynaptic kainate receptors (Contractor *et al*., [2001](#ejn13191-bib-0011){ref-type="ref"}), or presynaptic voltage‐dependent calcium channels (Gundlfinger *et al*., [2007](#ejn13191-bib-0024){ref-type="ref"}). Our results show that P2X~4~Rs only control FF in the presence of sufficient amounts of extracellular ATP, which are probably provided by activated microglia, whereas, in the absence of LPS‐microglia, FF is insensitive to P2X~4~R blockade.

Microglia‐derived adenosine but not ATP impacts on PPF {#ejn13191-sec-0021}
------------------------------------------------------

The decrease in PPF induced by LPS‐microglia, which was preserved in the presence of PPADS or 5‐BDBD but also in P2X~4~R KO slices, strongly suggests that adenosine but not ATP was involved in this effect. Activation of A~1~Rs at MF‐CA3 synapses is known to inhibit synaptic transmission (Scanziani *et al*., [1992](#ejn13191-bib-0056){ref-type="ref"}; Moore *et al*., [2003](#ejn13191-bib-0039){ref-type="ref"}; Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}), and its presynaptic localization has been confirmed by electron microscopy (Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}). The blockade by DPCPX of the decrease in PPF induced by LPS‐microglia and its mimicking by CCPA are good evidence that adenosine resulting from the degradation of microglia‐derived ATP modulates PPF. Unexpectedly, the blockade of P2X~4~Rs by 5‐BDBD on its own also reduced PPF. This could indicate that endogenous ATP in the presence of receptors blocked by 5‐BDBD would be more readily available to be converted into adenosine, activating A~1~R and leading to a decrease in PPF. Hence, PPF was not affected in P2X~4~R KO mice, supporting our contention that the effect of 5‐BDBD involves greater availability of adenosine acting on A~1~Rs rather than an effect of P2X~4~R.

Owing to a very low initial release probability, the PPF at MF‐CA3 synapses is assumed to be directly linked to the probability of glutamate release, which is dependent on the residual calcium concentration in the presynaptic terminal (Salin *et al*., [1996](#ejn13191-bib-0055){ref-type="ref"}; Nicoll & Schmitz, [2005](#ejn13191-bib-0043){ref-type="ref"}). Therefore, one could expect that microglia‐derived adenosine acting on A~1~Rs by reducing calcium influx into MF terminals (Gundlfinger *et al*., [2007](#ejn13191-bib-0024){ref-type="ref"}) would decrease PPF instead of increasing it. However, conflicting results have been reported for the impact of A~1~R activation on PPF at MF‐CA3 synapses, ranging from a reduction by half of PPF by DPCPX (Moore *et al*., [2003](#ejn13191-bib-0039){ref-type="ref"}) to no effect at all (Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}). These opposite results were attributed to differences in the ambient levels of adenosine in slices. Our results are consistent with a moderate level of ambient adenosine, as shown by the weak increase in basal synaptic transmission caused by DPCPX, similarly to what was previously reported (Kukley *et al*., [2005](#ejn13191-bib-0033){ref-type="ref"}; Rebola *et al*., [2008](#ejn13191-bib-0050){ref-type="ref"}), and by the lack of a significant effect on PPF.

Pathophysiological relevance of microglia‐derived purine modulation of MF‐CA3 synaptic plasticity {#ejn13191-sec-0022}
-------------------------------------------------------------------------------------------------

There is compelling evidence that the purinergic system is instrumental in neuroinflammation (Di Virgilio *et al*., [2009](#ejn13191-bib-0015){ref-type="ref"}), which can impact on synaptic function (Ben Achour & Pascual, [2010](#ejn13191-bib-0005){ref-type="ref"}; Pascual *et al*., [2012](#ejn13191-bib-0045){ref-type="ref"}). ATP is a major trigger of microglia activation through P2X~4~Rs and P2X~7~ receptors (Di Virgilio *et al*., [2009](#ejn13191-bib-0015){ref-type="ref"}; Koizumi *et al*., [2013](#ejn13191-bib-0031){ref-type="ref"}), and adenosine also regulates microglia responses through the activation of A~2A~Rs *in vivo* (Rebola *et al*., [2011](#ejn13191-bib-0051){ref-type="ref"}), by controlling the microglial production of inflammatory cytokines, and growth factors such as BDNF and ATP (Gomes *et al*., [2013](#ejn13191-bib-0023){ref-type="ref"}; George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}). By taking advantage of a simple paradigm based on the addition of activated N9 microglia releasing ATP, the present study provides evidence that microglia‐derived purines in a neuroinflammatory paradigm modulate, via presynaptic P2X~4~Rs and A~1~Rs, different forms of presynaptic short‐term plasticity at MF‐CA3 synapses. However, the simplicity of the paradigm used also introduced some limitations in the mechanistic process underlying this control of short‐term plasticity by microglia‐derived ATP. Indeed, our experimental approach does not allow us to rule out the participation of endogenous microglia, astrocytes and/or neurons in possible amplification of the N9 microglia‐derived ATP to control presynaptic short‐term plasticity at MF‐CA3 synapses. In this respect, a recent study showed that the production of tumour necrosis factor‐α and ATP by microglia was driving nearby astrocytes to release ATP, promoting, in turn, astroglial release of glutamate and a subsequent increase in CA1 synaptic transmission in acute hippocampal slices (Pascual *et al*., [2012](#ejn13191-bib-0045){ref-type="ref"}). However, this documented ATP‐induced ATP release from astrocytes occurs only for ATP concentrations in the high micromolar range (Anderson *et al*., [2004](#ejn13191-bib-0001){ref-type="ref"}), whereas we have previously estimated that N9 microglia release nanomolar concentrations of ATP (George *et al*., [2015](#ejn13191-bib-0021){ref-type="ref"}). Certainly, future studies will be required to unravel the intricate interplay between different cell types in the purinergic control of presynaptic short‐term plasticity at MF‐CA3 synapses triggered by a neuroinflammation‐associated increase in the concentration of microglia‐derived ATP.

The CA3 subregion of the hippocampus has been reported to be involved in the encoding, storage and subsequent retrieval of memories (Nakazawa *et al*., [2003](#ejn13191-bib-0040){ref-type="ref"}; Bischofberger *et al*., [2006](#ejn13191-bib-0007){ref-type="ref"}; Kesner, [2007](#ejn13191-bib-0026){ref-type="ref"}). Owing to the sparse connectivity between dentate gyrus granule cells and CA3 pyramidal neurons and the prominent ability of MF‐CA3 synapses to facilitate markedly the MF pathway has been particularly involved in the pattern separation process (Bischofberger *et al*., [2006](#ejn13191-bib-0007){ref-type="ref"}; Gilbert & Kesner, [2006](#ejn13191-bib-0022){ref-type="ref"}; Leutgeb *et al*., [2007](#ejn13191-bib-0035){ref-type="ref"}; Neves *et al*., [2008](#ejn13191-bib-0042){ref-type="ref"}). Therefore, a decrease in short‐term plasticity induced by neuroinflammation could impact on the pattern separation process. Relevant to this, it is well known that murine models of Alzheimer\'s disease, which show prominent neuroinflammation, have impaired spatial memory, as is also found in Alzheimer\'s patients. It would be interesting to use behavioural paradigms to test the pattern separation process in mice with conditional deletion of P2X~4~Rs and/or A~1~Rs in granule cells, in order to test the possible involvement of this subnetwork.
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